Addus HomeCare (NASDAQ:ADUS) Stock Rating Upgraded by Wall Street Zen

Addus HomeCare (NASDAQ:ADUS) was upgraded by analysts at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a note issued to investors on Monday.

Several other brokerages also recently weighed in on ADUS. Barclays lifted their target price on Addus HomeCare from $111.00 to $117.00 and gave the company an “underweight” rating in a research note on Tuesday, November 4th. BMO Capital Markets assumed coverage on shares of Addus HomeCare in a research note on Thursday, November 13th. They set a “market perform” rating and a $120.00 price objective on the stock. Truist Financial set a $135.00 target price on shares of Addus HomeCare and gave the company a “buy” rating in a research report on Wednesday, January 7th. Weiss Ratings restated a “hold (c+)” rating on shares of Addus HomeCare in a research report on Wednesday, January 21st. Finally, Royal Bank Of Canada upped their price target on shares of Addus HomeCare from $134.00 to $139.00 and gave the stock an “outperform” rating in a research note on Friday, November 7th. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $134.89.

Addus HomeCare Trading Down 10.6%

Addus HomeCare stock opened at $105.20 on Monday. Addus HomeCare has a 52-week low of $88.96 and a 52-week high of $124.43. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.14. The firm has a market capitalization of $1.94 billion, a price-to-earnings ratio of 20.19, a PEG ratio of 1.41 and a beta of 0.91. The firm has a 50-day moving average price of $109.68 and a two-hundred day moving average price of $113.11.

Institutional Trading of Addus HomeCare

Several institutional investors and hedge funds have recently bought and sold shares of the stock. Global Retirement Partners LLC increased its position in shares of Addus HomeCare by 395.7% in the fourth quarter. Global Retirement Partners LLC now owns 233 shares of the company’s stock worth $25,000 after acquiring an additional 186 shares in the last quarter. Larson Financial Group LLC boosted its stake in Addus HomeCare by 133.3% in the 3rd quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock worth $28,000 after purchasing an additional 136 shares during the period. Acumen Wealth Advisors LLC purchased a new position in Addus HomeCare during the 4th quarter worth approximately $29,000. Arax Advisory Partners raised its stake in Addus HomeCare by 95.8% during the 4th quarter. Arax Advisory Partners now owns 280 shares of the company’s stock valued at $30,000 after purchasing an additional 137 shares during the period. Finally, Private Trust Co. NA raised its stake in Addus HomeCare by 65.5% during the 4th quarter. Private Trust Co. NA now owns 283 shares of the company’s stock valued at $30,000 after purchasing an additional 112 shares during the period. Institutional investors and hedge funds own 95.35% of the company’s stock.

Key Addus HomeCare News

Here are the key news stories impacting Addus HomeCare this week:

• Positive Sentiment: Clear revenue and adjusted-profitability momentum — net service revenues rose ~25.6% Y/Y to about $373M and adjusted EBITDA grew ~33%, showing operating leverage that management highlighted on the call. Business Wire: Q4 Results
• Positive Sentiment: Management articulated a 2026 plan to drive margin leverage and tuck-in acquisitions while expanding personal-care revenue — a strategic message that supports medium‑term growth and margin expansion. Seeking Alpha: Strategy for 2026
• Neutral Sentiment: Adjusted EPS and some analyst-model metrics were presented positively (company cites adjusted EPS that improved Y/Y), but reporters note different ways of measuring (GAAP vs. adjusted). Read the call highlights for detail. TipRanks: Earnings Call Highlights
• Neutral Sentiment: Management engagement with investors continues (Raymond James conference participation) and the full earnings-call transcript is available for replay — useful for analysts parsing guidance and margin bridge details. Yahoo: Conference Participation Seeking Alpha: Call Transcript
• Negative Sentiment: Mixed headline metrics: some outlets report revenue narrowly below consensus and GAAP diluted EPS below certain Street forecasts (differences between GAAP and adjusted EPS drove confusion), which likely triggered profit-taking. QuiverQuant: Q4 Results – Mixed vs. Estimates
• Negative Sentiment: Insider sales and recent institutional rebalancing flagged by data providers (large reductions by some funds and multiple insider sales) add to near-term selling pressure and investor caution. QuiverQuant: Insider & Institutional Activity
• Negative Sentiment: Market reaction and sell-side commentary drove a notable intraday decline; coverage notes the price drop and trading volume spike as investors reprice near-term execution risk. AAII: Why ADUS Is Down

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.